Kolon Life Science Inc (102940) — Cash Flow Reinvestment Rate

Latest as of September 2025: 4.34x

Kolon Life Science Inc (102940) has a Cash Flow Reinvestment Rate of 4.34x as of September 2025, reinvesting ₩11.20 Billion (capex ₩8.05 Billion plus investments ₩-3.15 Billion) from operating cash flow of ₩2.58 Billion. Check 102940 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

4.34x
(Capex + Investments) / Operating CF

Total Reinvested

₩11.20 Billion
Capex + Investments

Operating Cash Flow

₩2.58 Billion
KRW

Capital Expenditures

₩8.05 Billion
KRW

Kolon Life Science Inc Cash Flow Reinvestment Rate (2011–2016)

Historical reinvestment intensity for Kolon Life Science Inc across 5 annual periods. Explore 102940 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Kolon Life Science Inc (2011–2016)

Year-by-year capital reinvestment analysis for Kolon Life Science Inc. For live market cap and broader valuation context, see how much is Kolon Life Science Inc worth.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2016 1.46x ₩41.03 Billion ₩28.11 Billion ₩16.14 Billion ▼ -24.3%
2015 1.93x ₩40.11 Billion ₩20.81 Billion ₩15.22 Billion ▼ -7.7%
2014 2.09x ₩25.26 Billion ₩12.10 Billion ₩15.01 Billion ▼ -24.9%
2012 2.78x ₩64.96 Billion ₩23.37 Billion ₩61.01 Billion ▲ +2.9%
2011 2.70x ₩31.47 Billion ₩11.65 Billion ₩27.52 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow